BDX
BECTON DICKINSON & CO
NYSE · Healthcare · Medical - Instruments & Supplies · US
$197.95
+1.43%Year over year
Reported trailing growth
- Revenue
- -2.6%
- EBITDA
- -8.5%
- EBIT
- -18.2%
- EPS
- -40.4%
- Free cash flow
- +2.2%
- Operating cash flow
- +2.5%
Forward estimates
Based on analyst estimates
- Revenue
- -5.5%
- EBITDA
- +44.9%
- EPS
- +296.9%
Three-year CAGR
- Revenue
- +5.0%
- EBITDA
- +4.0%
- EBIT
- +4.1%
- Net income
- -1.9%
- EPS
- -0.5%
- Free cash flow
- +17.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026